CompletedNot Applicable

Optimizing the Pharmacotherapy of Vascular Surgery Patients at Hospital Admission, at Discharge and at Post-discharge Check-up: Quasi-experimental Clinical Uncontrolled Trial (PHAROS)

Slovakia105 participantsStarted 2021-09-01

Plain-language summary

This project aims to assess the impact of pharmaceutical care in collaboration with physicians on prevalence of DRPs at hospital admission and discharge in patients with carotid artery disease or lower extermity artery disease hospitalized at the Department of Vascular Surgery. The key focus area of this project will be the identification of DRPs, their occurrence and type. As a part of further research, the investigators want to analyze the a) acceptance rate of pharmaceutical intervention by physicians. Proportion of accepted interventions by physicians was calculated and b) patients' understanding of his/her pharmacotherapy assessed on a three-point scale at hospital admission. Hypothesis: Null hypothesis: Pharmaceutical care provided at hospital admission and at hospital discharge does not reduce prevalence rates of DRPs in patients with carotid artery disease or lower extermity artery disease hospitalized at the Department of Vascular Surgery. Alternative hypothesis: Pharmaceutical care provided at hospital admission and at hospital discharge reduces prevalence rates of DRPs in patients with carotid artery disease or lower extermity artery disease hospitalized at the Department of Vascular Surgery. Primary outcomes: Change in the prevalence rate of DRPs at hospital admission vs. hospital discharge. Secondary outcomes: 1. acceptance rate of pharmaceutical intervention by physician 2. patients' understanding of his/her pharmacotherapy

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥18 years at the date of admission for hospitalization
✓. patients taking at least 3 medications
✓. patients with carotid artery disease or lower extremity artery disease

Exclusion criteria

✕. Acute patients.Due to the urgent health condition, medication reconciliation is not the priority in these patients, furthermore, rendering the BPMH collection impossible.
✕. Patients transferred from other hospitals/wards
✕. Not willing to sign the informed consent form for the study
✕. Not understanding Slovak language
✕. Presence of any mental disorder affecting memory and recall ability (such as Alzheimer's disease)
✕. Any other reason at the discretion of the investigator why he/she deems the participant not eligible for study participation (all such reasons will be recorded)

What they're measuring

Change in prevalence rate of drug related problems

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT04930302

SponsorNational Institute of Cardiovascular Diseases, Slovakia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-30

View on ClinicalTrials.gov More Medication Errors and Other Product Use Errors and Issues trials